摘要
双酚A (BPA)是一种工业上普遍存在的化合物,经常用于合成聚合物和环氧树脂。双酚a是公认的内分泌干扰物和异种雌激素化合物。流行病学和实验研究的证据表明,围产期暴露于BPA(妊娠和/或哺乳期)会增加各种疾病的风险,包括心血管系统。发育规划指的是在发育的关键窗口期,环境的破坏会影响身体系统的结构和生理,在后期造成永久性的变化。双酚a影响后代患非传染性疾病的发育程序。在这篇综述中,我们通过已发表的流行病学和实验证据,讨论了与围产期BPA暴露相关的心血管疾病的发展规划。大多数研究报告发现,围产期BPA暴露与胎儿、新生儿和成年期不良心血管反应呈正相关。可能的潜在机制包括心肌发育、自主张力、胶原和非胶原细胞外基质、心脏重塑和钙稳态以及线粒体能量代谢相关基因的表观遗传修饰。表观遗传学可以改变任何疾病的结果。因此,在这篇综述中,我们还讨论了表观遗传学在预防围产期BPA暴露后心血管疾病中的作用。我们还强调了未来与心血管介入相关的治疗和药物输送如何基于表观遗传标记。
关键词: 双酚A,毒性,心血管系统,发育程序,表观遗传学,双酚S。
Current Medicinal Chemistry
Title:Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring
Volume: 29 Issue: 24
关键词: 双酚A,毒性,心血管系统,发育程序,表观遗传学,双酚S。
摘要: Bisphenol A (BPA) is an industrial ubiquitous compound, frequently used to produce synthetic polymers and epoxy resins. BPA is a well-recognized endocrine disruptor and xenoestrogen compound. Evidence from epidemiological and experimental studies suggests that perinatal BPA exposure (gestation and/or lactation) increases the risk of developing various diseases, including the cardiovascular system. Developmental programming refers to environmental insults during the critical window of development that affect the structure and physiology of body systems, causing permanent changes in later stages. BPA influences the developmental programming of non-communicable diseases in the offspring. In the present review, we discuss the developmental programming of cardiovascular diseases related to perinatal exposure to BPA, supported by epidemiological and experimental evidence from published literature. The majority of the reported studies found a positive association between perinatal BPA exposure and adverse cardiovascular repercussions in the fetal, neonatal, and adulthood stages. The possible underlying mechanisms include epigenetic modifications of genes involved in cardiac muscle development, autonomic tone, collagenous and non-collagenous extracellular matrix, cardiac remodeling and calcium homeostasis, and mitochondrial energy metabolism. Epigenetics can modify the outcome of any disease. Hence, in the present review, we also discuss the role of epigenetics in preventing cardiovascular diseases following perinatal exposure to BPA. We also highlight how future treatment and drug delivery related to cardiovascular involvement could be based on epigenetic markers.
Export Options
About this article
Cite this article as:
Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring, Current Medicinal Chemistry 2022; 29 (24) . https://dx.doi.org/10.2174/0929867328666211206111835
DOI https://dx.doi.org/10.2174/0929867328666211206111835 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multifaceted Role of Neuropilins in Cancer
Current Medicinal Chemistry Haploinsufficiency of DNA Damage Response Genes and their Potential Influence in Human Genomic Disorders
Current Genomics Repair of Dilated Aortic Root and Sinotubular Junction Using a Stabilizer Ring
Recent Patents on Cardiovascular Drug Discovery The Safety of Medications for the Treatment of Bipolar Disorder During Pregnancy and the Puerperium
Current Drug Safety Congenital Parenchymal Lesions of the Lung
Current Respiratory Medicine Reviews Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity
Anti-Cancer Agents in Medicinal Chemistry The Finely Regulating Well-defined Functional Polymeric Nanocarriers for Anti-tumor Immunotherapy
Mini-Reviews in Medicinal Chemistry Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Expression and Function of MicroRNAs in Enamel Development
Current Stem Cell Research & Therapy Generation of Human Cardiomyocytes for Cardiac Regenerative Therapies: Differentiation and Direct Reprogramming
Current Pharmaceutical Design Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cardiac Innervation and Sudden Cardiac Death
Current Cardiology Reviews Decreased Expression and Altered Methylation of Syncytin-1 Gene in Human Placentas Associated with Preeclampsia
Current Pharmaceutical Design Ruptured Multiple Mycotic Aneurysms Following Infective Endocarditis: Effectiveness of Catheter-based Techniques Using N-butyl Cyanoacrylate in a Hemorrhage-induced Coagulopathy
Current Medical Imaging The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews RhoGEFs in Cell Motility: Novel Links Between Rgnef and Focal Adhesion Kinase
Current Molecular Medicine Angiogenesis-regulating microRNAs and Ischemic Stroke
Current Vascular Pharmacology Pregnancy in Type 2 Diabetes Mellitus - Problems & Promises
Current Diabetes Reviews Roles of Nicotinic Acetylcholine Receptors in Stem Cell Survival/Apoptosis, Proliferation and Differentiation
Current Molecular Medicine Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy